JANE STREET GROUP, LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 166 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$626,562
+146.3%
110,896
+79.1%
0.00%
Q1 2024$254,425
-35.3%
61,904
-33.6%
0.00%
Q4 2023$393,367
-62.5%
93,215
-61.6%
0.00%
Q3 2023$1,048,706
+271.9%
242,756
+467.3%
0.00%
Q2 2023$282,006
+118.6%
42,793
+275.4%
0.00%
Q1 2022$129,000
-53.6%
11,400
-35.6%
0.00%
Q4 2021$278,000
-64.5%
17,700
-61.3%
0.00%
Q3 2021$784,000
-23.0%
45,743
-3.4%
0.00%
Q2 2021$1,018,000
+281.3%
47,335
+166.6%
0.00%
Q1 2021$267,0000.0%17,757
-12.6%
0.00%
Q4 2020$267,000
-18.1%
20,306
-39.7%
0.00%
Q3 2020$326,000
-15.1%
33,659
+43.8%
0.00%
-100.0%
Q4 2019$384,000
-30.3%
23,414
-28.4%
0.00%
-50.0%
Q1 2018$551,000
+77.2%
32,682
+47.3%
0.00%
+100.0%
Q1 2017$311,000
-25.4%
22,187
-15.1%
0.00%
-50.0%
Q4 2016$417,000
-17.1%
26,147
-13.4%
0.00%0.0%
Q3 2016$503,000
+151.5%
30,195
+68.9%
0.00%
+100.0%
Q2 2016$200,000
+47.1%
17,873
+67.0%
0.00%0.0%
Q2 2015$136,000
-38.5%
10,700
-30.8%
0.00%
-50.0%
Q4 2014$221,000
-35.8%
15,454
-53.4%
0.00%
-50.0%
Q3 2014$344,000
+31.3%
33,163
+105.4%
0.00%
+33.3%
Q1 2014$262,00016,1440.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,525,476$74,263,0004.09%
ARMISTICE CAPITAL, LLC 2,828,000$46,407,0002.68%
Birchview Capital, LP 80,000$1,313,0000.95%
GLOBEFLEX CAPITAL L P 145,426$2,386,0000.45%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 231,733$3,803,0000.36%
361 CAPITAL LLC 77,630$1,274,0000.35%
CADENCE CAPITAL MANAGEMENT LLC 152,428$2,501,0000.27%
BOOTHBAY FUND MANAGEMENT, LLC 148,000$2,429,0000.21%
EMERALD ADVISERS, LLC 258,497$4,242,0000.18%
EMERALD MUTUAL FUND ADVISERS TRUST 251,730$4,131,0000.17%
View complete list of VANDA PHARMACEUTICALS INC shareholders